Skip to main content

Advertisement

SpringerLink
Log in

Battle of Animal Models

  • Invited Review
  • Published:
Journal of Neuroimmune Pharmacology Aims and scope Submit manuscript

Abstract

This is a brief summary of the animal models session held during the 12th Annual Meeting of the Society on NeuroImmune Pharmacology, Santa Fe, NM, USA. This session provided important information for participants on availability and utility of animal models for the studies of HIV-1 central nervous system infection and drug abuse. It highlighted animal model relevance to human disease/condition, its utility for the studies of pathogenesis, potential importance for the development of therapeutics, and demonstrated limitations/pitfalls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Barr MC, Billaud JN, Selway DR, Huitron-Resendiz S, Osborn KG, Henriksen SJ, Phillips TR (2000) Effects of multiple acute morphine exposures on feline immunodeficiency virus disease progression. J Infect Dis 182:725–732

    Article  PubMed  CAS  Google Scholar 

  • Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Henriksen SJ, Phillips TR (2003) Escalating morphine exposures followed by withdrawal in feline immunodeficiency virus-infected cats: a model for HIV infection in chronic opiate abusers. Drug Alcohol Depend 72:141–149

    Article  PubMed  CAS  Google Scholar 

  • Burdo TH, Marcondes MC, Lanigan CM, Penedo MC, Fox HS (2005) Susceptibility of Chinese rhesus monkeys to SIV infection. Aids 19:1704–1706

    Article  PubMed  Google Scholar 

  • Cloak CC, Chang L, Ernst T, Barr MC, Huitron-Resendiz S, Sanchez-Alavez M, Phillips TR, Henriksen S (2004) Methamphetamine and AIDS: 1HMRS studies in a feline model of human disease. J Neuroimmunol 147:16–20

    Article  PubMed  CAS  Google Scholar 

  • Cohen J (2000) AIDS research. Vaccine studies stymied by shortage of animals. Science 287:959–960

    Article  PubMed  CAS  Google Scholar 

  • Contet C, Gaveriaux-Ruff C, Matifas A, Caradec C, Champy MF, Kieffer BL (2006) Dissociation of analgesic and hormonal responses to forced swim stress using opioid receptor knockout mice. Neuropsychopharmacology 31:1733–1744

    Article  PubMed  CAS  Google Scholar 

  • Donahoe RM (2004) Multiple ways that drug abuse might influence AIDS progression: clues from a monkey model. J Neuroimmunol 147:28–32

    Article  PubMed  CAS  Google Scholar 

  • Donahoe RM, Vlahov D (1998) Opiates as potential cofactors in progression of HIV-1 infections to AIDS. J Neuroimmunol 83:77–87

    Article  PubMed  CAS  Google Scholar 

  • Donahoe RM, Byrd LD, McClure HM, Fultz P, Brantley M, Marsteller F, Ansari AA, Wenzel D, Aceto M (1993) Consequences of opiate-dependency in a monkey model of AIDS. Adv Exp Med Biol 335:21–28

    PubMed  CAS  Google Scholar 

  • Dou H, Birusingh K, Faraci J, Gorantla S, Poluektova LY, Maggirwar SB, Dewhurst S, Gelbard HA, Gendelman HE (2003) Neuroprotective activities of sodium valproate in a murine model of human immunodeficiency virus-1 encephalitis. J Neurosci 23:9162–9170

    PubMed  CAS  Google Scholar 

  • Dou H, Ellison B, Bradley J, Kasiyanov A, Poluektova LY, Xiong H, Maggirwar S, Dewhurst S, Gelbard HA, Gendelman HE (2005) Neuroprotective mechanisms of lithium in murine human immunodeficiency virus-1 encephalitis. J Neurosci 25:8375–8385

    Article  PubMed  CAS  Google Scholar 

  • Fox HS, Weed MR, Huitron-Resendiz S, Baig J, Horn TF, Dailey PJ, Bischofberger N, Henriksen SJ (2000) Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys. J Clin Invest 106:37–45

    Article  PubMed  CAS  Google Scholar 

  • Gaveriaux-Ruff C, Matthes HW, Peluso J, Kieffer BL (1998) Abolition of morphine-immunosuppression in mice lacking the mu-opioid receptor gene. Proc Natl Acad Sci USA 95:6326–6330

    Article  PubMed  CAS  Google Scholar 

  • Gaveriaux-Ruff C, Simonin F, Filliol D, Kieffer BL (2003) Enhanced humoral response in kappa-opioid receptor knockout mice. J Neuroimmunol 134:72–81

    Article  PubMed  CAS  Google Scholar 

  • Gorantla S, Miller E, Klasek H, Morehead J, Walters L, Gendelman HE, Poluektova L (2006) Immunodeficient models of HIV-1 encephalitis (HIVE). In: 12th Annual Meeting of the Society on NeuroImmune Pharmacology. Santa Fe, NM: Society on NeuroImmune Pharmacology

  • Hauser KF, El-Hage N, Buch S, Berger JR, Tyor WR, Nath A, Bruce-Keller AJ, Knapp PE (2005) Molecular targets of opiate drug abuse in neuroAIDS. Neurotox Res 8:63–80

    Article  PubMed  Google Scholar 

  • Holterman L, Niphuis H, ten Haaft PJ, Goudsmit J, Baskin G, Heeney JL (1999) Specific passage of simian immunodeficiency virus from end-stage disease results in accelerated progression to AIDS in rhesus macaques. J Gen Virol 80:3089–3097

    PubMed  CAS  Google Scholar 

  • Hook S, Prout M, Camberis M, Konig M, Zimmer A, Van Heeke G, Le Gros G (2000) Th2-dependent airway eosinophilia is regulated by preproenkephalin. J Neuroimmunol 107:59–65

    Article  PubMed  CAS  Google Scholar 

  • Horn TF, Huitron-Resendiz S, Weed MR, Henriksen SJ, Fox HS (1998) Early physiological abnormalities after simian immunodeficiency virus infection. Proc Natl Acad Sci USA 95:15072–15077

    Article  PubMed  CAS  Google Scholar 

  • Joag SV, Li Z, Foresman L, Stephens EB, Zhao LJ, Adany I, Pinson DM, McClure HM, Narayan O (1996) Chimeric simian/human immunodeficiency virus that causes progressive loss of CD4+ T cells and AIDS in pig-tailed macaques. J Virol 70:3189–3197

    PubMed  CAS  Google Scholar 

  • Johnson WE, Lifson JD, Lang SM, Johnson RP, Desrosiers RC (2003) Importance of B-cell responses for immunological control of variant strains of simian immunodeficiency virus. J Virol 77:375–381

    Article  PubMed  CAS  Google Scholar 

  • Katner SN, Flynn CT, Von Huben SN, Kirsten AJ, Davis SA, Lay CC, Cole M, Roberts AJ, Fox HS, Taffe MA (2004) Controlled and behaviorally relevant levels of oral ethanol intake in rhesus macaques using a flavorant-fade procedure. Alcohol Clin Exp Res 28:873–883

    PubMed  Google Scholar 

  • Kieffer BL, Gaveriaux-Ruff C (2002) Exploring the opioid system by gene knockout. Prog Neurobiol 66:285–306

    Article  PubMed  CAS  Google Scholar 

  • Kumar R, Orsoni S, Norman L, Verma AS, Tirado G, Giavedoni LD, Staprans S, Miller GM, Buch SJ, Kumar A (2006) Chronic morphine exposure causes pronounced virus replication in cerebral compartment and accelerated onset of AIDS in SIV/SHIV-infected Indian rhesus macaques. Virology 354:192–206

    Article  PubMed  CAS  Google Scholar 

  • Kumar R, Torres C, Yamamura Y, Rodriguez I, Martinez M, Staprans S, Donahoe RM, Kraiselburd E, Stephens EB, Kumar A (2004) Modulation by morphine of viral set point in rhesus macaques infected with simian immunodeficiency virus and simian–human immunodeficiency virus. J Virol 78:11425–11428

    Article  PubMed  CAS  Google Scholar 

  • Lane TE, Buchmeier MJ, Watry DD, Jakubowski DB, Fox HS (1995) Serial passage of microglial SIV results in selection of homogeneous env quasispecies in the brain. Virology 212:458–465

    Article  PubMed  CAS  Google Scholar 

  • Limoges J, Persidsky Y, Poluektova L, Rasmussen J, Ratanasuwan W, Zelivyanskaya M, McClernon DR, Lanier ER, Gendelman HE (2000) Evaluation of antiretroviral drug efficacy for HIV-1 encephalitis in SCID mice [see comments]. Neurology 54:379–389

    PubMed  CAS  Google Scholar 

  • Limoges J, Poluektova L, Ratanasuwan W, Rasmussen J, Zelivyanskaya M, McClernon DR, Lanier ER, Gendelman HE, Persidsky Y (2001) The efficacy of potent anti-retroviral drug combinations tested in a murine model of HIV-1 encephalitis. Virology 281:21–34

    Article  PubMed  CAS  Google Scholar 

  • Ling B, Veazey RS, Luckay A, Penedo C, Xu K, Lifson JD, Marx PA (2002) SIV(mac) pathogenesis in rhesus macaques of Chinese and Indian origin compared with primary HIV infections in humans. Aids 16:1489–1496

    Article  PubMed  Google Scholar 

  • Madden LJ, Flynn CT, Zandonatti MA, May M, Parsons LH, Katner SN, Henriksen SJ, Fox HS (2005) Modeling human methamphetamine exposure in nonhuman primates: chronic dosing in the rhesus macaque leads to behavioral and physiological abnormalities. Neuropsychopharmacology 30:350–359

    Article  PubMed  CAS  Google Scholar 

  • Marcondes MC, Phillipson CA, Fox HS (2003) Distinct clonal repertoire of brain CD8+ cells in simian immunodeficiency virus infection. Aids 17:1605–1611

    Article  PubMed  CAS  Google Scholar 

  • Marthas ML, Lu D, Penedo MC, Hendrickx AG, Miller CJ (2001) Titration of an SIVmac251 stock by vaginal inoculation of Indian and Chinese origin rhesus macaques: Transmission efficiency, viral loads, and antibody responses. AIDS Res Hum Retroviruses 17:1455–1466

    Article  PubMed  CAS  Google Scholar 

  • Mazzucchelli R, Amadio M, Curreli S, Denaro F, Bemis K, Reid W, Bryant J, Riva A, Galli M, Zella D (2004) Establishment of an ex vivo model of monocytes-derived macrophages differentiated from peripheral blood mononuclear cells (PBMCs) from HIV-1 transgenic rats. Mol Immunol 41:979–984

    PubMed  CAS  Google Scholar 

  • Nath A, Hauser KF, Wojna V, Booze RM, Maragos W, Prendergast M, Cass W, Turchan JT (2002) Molecular basis for interactions of HIV and drugs of abuse. J Acquir Immune Defic Syndr 31:S62–S69

    PubMed  CAS  Google Scholar 

  • Nitkiewicz J, Chao W, Bentsman G, Li J, Kim SY, Choi SY, Grunig G, Gelbard H, Potash MJ, Volsky DJ (2004) Productive infection of primary murine astrocytes, lymphocytes, and macrophages by human immunodeficiency virus type 1 in culture. J Neurovirol 10:400–408

    Article  PubMed  CAS  Google Scholar 

  • Nukuna A, Gendelman HE, Limoges J, Rasmussen J, Poluektova L, Ghorpade A, Persidsky Y (2004) Levels of human immunodeficiency virus type 1 (HIV-1) replication in macrophages determines the severity of murine HIV-1 encephalitis. J Neurovirol 10(Suppl 1):82–90

    Article  PubMed  Google Scholar 

  • Parker RA, Regan MM, Reimann KA (2001) Variability of viral load in plasma of rhesus monkeys inoculated with simian immunodeficiency virus or simian-human immunodeficiency virus: implications for using nonhuman primate AIDS models to test vaccines and therapeutics. J Virol 75:11234–11238

    Article  PubMed  CAS  Google Scholar 

  • Persidsky Y, Buttini M, Limoges J, Bock P, Gendelman HE (1997) An analysis of HIV-1-associated inflammatory products in brain tissue of humans and SCID mice with HIV-1 encephalitis. J Neurovirol 3:401–416

    Article  PubMed  CAS  Google Scholar 

  • Persidsky Y, Limoges J, McComb R, Bock P, Baldwin T, Tyor W, Patil A, Nottet HS, Epstein L, Gelbard H, Flanagan E, Reinhard J, Pirruccello SJ, Gendelman HE (1996) Human immunodeficiency virus encephalitis in SCID mice. Am J Pathol 149:1027–1053

    PubMed  CAS  Google Scholar 

  • Persidsky Y, Limoges J, Rasmussen J, Zheng J, Gearing A, Gendelman HE (2001) Reduction in glial immunity and neuropathology by a PAF antagonist and an MMP and TNFalpha inhibitor in SCID mice with HIV-1 encephalitis. J Neuroimmunol 114:57–68

    Article  PubMed  CAS  Google Scholar 

  • Persidsky Y, Potula R, Haorah J (2005) Rodent model systems for studies of HIV-1 associated dementia. Neurotox Res 8:91–106

    Article  PubMed  CAS  Google Scholar 

  • Philippe D, Dubuquoy L, Groux H, Brun V, Chuoi-Mariot MT, Gaveriaux-Ruff C, Colombel JF, Kieffer BL, Desreumaux P (2003) Anti-inflammatory properties of the mu opioid receptor support its use in the treatment of colon inflammation. J Clin Invest 111:1329–1338

    Article  PubMed  CAS  Google Scholar 

  • Phillips TR, Billaud JN, Henriksen SJ (2000) Methamphetamine and HIV-1: potential interactions and the use of the FIV/cat model. J Psychopharmacol 14:244–250

    Article  PubMed  CAS  Google Scholar 

  • Phillips TR, Prospero-Garcia O, Puaoi DL, Lerner DL, Fox HS, Olmsted RA, Bloom FE, Henriksen SJ, Elder JH (1994) Neurological abnormalities associated with feline immunodeficiency virus infection. J Gen Virol 75(Pt 5):979–987

    Article  PubMed  CAS  Google Scholar 

  • Phillips TR, Prospero-Garcia O, Wheeler DW, Wagaman PC, Lerner DL, Fox HS, Whalen LR, Bloom FE, Elder JH, Henriksen SJ (1996) Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. J Neurovirol 2:388–396

    Article  PubMed  CAS  Google Scholar 

  • Poluektova L, Gorantla S, Faraci J, Birusingh K, Dou H, Gendelman HE (2004) Neuroregulatory events follow adaptive immune-mediated elimination of HIV-1-infected macrophages: studies in a murine model of viral encephalitis. J Immunol 172:7610–7617

    PubMed  CAS  Google Scholar 

  • Poluektova LY, Munn DH, Persidsky Y, Gendelman HE (2002) Generation of cytotoxic T cells against virus-infected human brain macrophages in a murine model of HIV-1 encephalitis. J Immunol 168:3941–3949

    PubMed  CAS  Google Scholar 

  • Potash MJ, Chao W, Bentsman G, Paris N, Saini M, Nitkiewicz J, Belem P, Sharer L, Brooks AI, Volsky DJ (2005) A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness. Proc Natl Acad Sci USA 102:3760–3765

    Article  PubMed  CAS  Google Scholar 

  • Potula R, Haorah J, Knipe B, Leibhart J, Chrastil J, Heilman D, Dou H, Reddy R, Ghorpade A, Persidsky Y (2006) Alcohol abuse enhances neuroinflammation and impairs immune responses in an animal model of human immunodeficiency virus-1 encephalitis. Am J Pathol 168:1335–1344

    Article  PubMed  CAS  Google Scholar 

  • Potula R, Poluektova L, Knipe B, Chrastil J, Heilman D, Dou H, Takikawa O, Munn DH, Gendelman HE, Persidsky Y (2005) Inhibition of Indoleamine 2,3-dioxygenase (IDO) enhances elimination of virus-infected macrophages in animal model of HIV-1 encephalitis. Blood 106:2382–2390

    Article  PubMed  CAS  Google Scholar 

  • Prospero-Garcia O, Gold LH, Fox HS, Polis I, Koob GF, Bloom FE, Henriksen SJ (1996) Microglia-passaged simian immunodeficiency virus induces neurophysiological abnormalities in monkeys. Proc Natl Acad Sci USA 93:14158–14163

    Article  PubMed  CAS  Google Scholar 

  • Ray PE, Liu XH, Robinson LR, Reid W, Xu L, Owens JW, Jones OD, Denaro F, Davis HG, Bryant JL (2003) A novel HIV-1 transgenic rat model of childhood HIV-1-associated nephropathy. Kidney Int 63:2242–2253

    Article  PubMed  Google Scholar 

  • Refojo D, Kovalovsky D, Young JI, Rubinstein M, Holsboer F, Reul JM, Low MJ, Arzt E (2002) Increased splenocyte proliferative response and cytokine production in beta-endorphin-deficient mice. J Neuroimmunol 131:126–134

    Article  PubMed  CAS  Google Scholar 

  • Reid W, Sadowska M, Denaro F, Rao S, Foulke J Jr, Hayes N, Jones O, Doodnauth D, Davis H, Sill A, O’Driscoll P, Huso D, Fouts T, Lewis G, Hill M, Kamin-Lewis R, Wei C, Ray P, Gallo RC, Reitz M, Bryant J (2001) An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction. Proc Natl Acad Sci USA 98:9271–9276

    Article  PubMed  CAS  Google Scholar 

  • Reimann KA, Li JT, Veazey R, Halloran M, Park IW, Karlsson GB, Sodroski J, Letvin NL (1996) A chimeric simian/human immunodeficiency virus expressing a primary patient human immunodeficiency virus type 1 isolate env causes an AIDS-like disease after in vivo passage in rhesus monkeys. J Virol 70:6922–6928

    PubMed  CAS  Google Scholar 

  • Reynolds PD, Roveda KP, Tucker JA, et al. (2003) Demands for rhesus monkeys in biomedical research: a workshop report. Ilar J 44:222–235

    Google Scholar 

  • Roberts ES, Zandonatti MA, Watry DD, Madden LJ, Henriksen SJ, Taffe MA, Fox HS (2003) Induction of pathogenic sets of genes in macrophages and neurons in neuroAIDS. Am J Pathol 162:2041–2057

    Google Scholar 

  • Sharma DP, Zink MC, Anderson M, Adams R, Clements JE, Joag SV, Narayan O (1992) Derivation of neurotropic simian immunodeficiency virus from exclusively lymphocytetropic parental virus: pathogenesis of infection in macaques. J Virol 66:3550–3556

    PubMed  CAS  Google Scholar 

  • Smith SM, Holland B, Russo C, Dailey PJ, Marx PA, Connor RI (1999) Retrospective analysis of viral load and SIV antibody responses in rhesus macaques infected with pathogenic SIV: predictive value for disease progression. AIDS Res Hum Retroviruses 15:1691–1701

    Article  PubMed  CAS  Google Scholar 

  • Suzuki S, Chuang AJ, Chuang LF, Doi RH, Chuang RY (2002) Morphine promotes simian acquired immunodeficiency syndrome virus replication in monkey peripheral mononuclear cells: induction of CC chemokine receptor 5 expression for virus entry. J Infect Dis 185:1826–1829

    Article  PubMed  CAS  Google Scholar 

  • Ten Haaft P, Verstrepen B, Uberla K, Rosenwirth B, Heeney J (1998) A pathogenic threshold of virus load defined in simian immunodeficiency virus– or simian–human immunodeficiency virus-infected macaques. J Virol 72:10281–10285

    PubMed  CAS  Google Scholar 

  • Traggiai E, Chicha L, Mazzucchelli L, Bronz L, Piffaretti JC, Lanzavecchia A, Manz MG (2004) Development of a human adaptive immune system in cord blood cell-transplanted mice. Science 304:104–107

    Article  PubMed  CAS  Google Scholar 

  • Trichel AM, Rajakumar PA, Murphey-Corb M (2002) Species-specific variation in SIV disease progression between Chinese and Indian subspecies of rhesus macaque. J Med Primatol 31:171–178

    Article  PubMed  CAS  Google Scholar 

  • Watry D, Lane TE, Streb M, Fox HS (1995) Transfer of neuropathogenic simian immunodeficiency virus with naturally infected microglia. Am J Pathol 146:914–923

    PubMed  CAS  Google Scholar 

  • Watson A, Ranchalis J, Travis B, McClure J, Sutton W, Johnson PR, Hu SL, Haigwood NL (1997) Plasma viremia in macaques infected with simian immunodeficiency virus: plasma viral load early in infection predicts survival. J Virol 71:284–290

    PubMed  CAS  Google Scholar 

  • Zink WE, Anderson E, Boyle J, Hock L, Rodriguez-Sierra J, Xiong H, Gendelman HE, Persidsky Y (2002) Impaired spatial cognition and synaptic potentiation in a murine model of human immunodeficiency virus type 1 encephalitis. J Neurosci 22:2096–2105

    PubMed  CAS  Google Scholar 

Download references

Acknowledgements

These works were supported by NIH grants DA007058, DA016149 and DA019836 (to Dr. Chang), DA17618 and NS54580 (to Dr. Volsky), RR15635 (to Dr. Poluektova), NS043985, AA015913 and MH65151 (Dr. Persidsky), DA12824, DA020416, and MH062261 (Dr. Fox), DA015013 and AA015045 (Dr. Kumar), DA12444 and MH47680 (Dr. Henriksen).

Author information

Authors and Affiliations

  1. Departments of Pharmacology/Experimental Neuroscience and Pathology/Microbiology, University of Nebraska Medical Center, 985215 Nebraska Medical Center, Omaha, NE, 68198-5215, USA

    Yuri Persidsky

  2. Department of Neuropharmacology, The Scripps Research Institute, La Jolla, California, USA

    Howard Fox

Authors
  1. Yuri Persidsky
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Howard Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yuri Persidsky.

Additional information

Persidsky and Fox contributed equally to this article.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Persidsky, Y., Fox, H. Battle of Animal Models. Jrnl Neuroimmune Pharm 2, 171–177 (2007). https://doi.org/10.1007/s11481-006-9046-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11481-006-9046-y

Keywords

Search

Navigation